| PERIOD ENDING | 31-Dec-08 | 31-Dec-07 | | Total Revenue |
-
|
-
| | Cost of Revenue |
-
|
-
| | | Gross Profit |
-
|
-
| | | Operating Expenses | | Research Development | 7,054 | 6,747 | | Selling General and Administrative | 7,499 | 4,666 | | Non Recurring |
-
|
-
| | Others |
-
|
-
| | | | Total Operating Expenses |
-
|
-
| | | | Operating Income or Loss | (14,553) | (11,413) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 180 | 448 | | Earnings Before Interest And Taxes | (14,373) | (10,965) | | Interest Expense |
-
|
-
| | Income Before Tax | (14,373) | (10,965) | | Income Tax Expense |
-
| 25 | | Minority Interest |
-
|
-
| | | | Net Income From Continuing Ops | (14,373) | (10,990) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
| | Extraordinary Items |
-
|
-
| | Effect Of Accounting Changes |
-
|
-
| | Other Items |
-
|
-
| | | | Net Income | (14,373) | (10,990) | | Preferred Stock And Other Adjustments |
-
|
-
| | | Net Income Applicable To Common Shares | ($14,373) | ($10,990) |
|
0.51% Nasdaq 
0.01 (0.22%) 
Income Statement
